Inhibition of transforming growth factor β signaling in MCF-7 cells results in resistance to tumor necrosis factor α: A role for Bcl-2

Cell Growth and Differentiation

Volumn 12, Issue 2, 2001, Pages 109-117

  Tobin, S W ^a   Brown, M K ^a   Douville, K ^a   Payne, D C ^a   Eastman, A ^a   Arrick, B A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE; CYTOKINES; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035119542     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. The transforming growth factor-βs
2. Physiological actions and clinical applications of transforming growth factor-β (TGF-β)
3. The biological role of transforming growth factor β in cancer development
4. Cyclosporin induces cancer progression by a cell-autonomous mechanism
5. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation
6. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
7. Early castration-induced upregulation of transforming growth factor β1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients
8. Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468
9. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro
10. Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene
11. Tumor necrosis factor α enhances secretion of transforming growth factor β2 in MCF-7 breast cancer cells
12. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
13. Inactive type II and type I receptors for TGF β are dominant inhibitors of TGF β-dependent transcription
14. Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region
15. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
16. An essential role For NF-κB in preventing TNF-α-induced cell death
17. Suppression of TNF-α-induced apoptosis by NF-κB
18. NF-κB antiapoptosis. Induction of TRAF1 and TRAF2 and c-IAP1 and c-IPA2 to suppress caspase 8 activation
19. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of 1κBα
20. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons
21. Transforming growth factor β1-induced apoptosis in human ovarian carcinoma cells: Protection by the antioxidant N-acetylcysteine and bcl-2
22. Expression of bcl-2 and bax in TGF-β1-induced apoptosis of L1210 leukemic cells
23. 1-induced apoptosis in colorectal adenoma cells
24. Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells
25. Ligand-independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors
26. Apoptotic cell death and tissue remodelling during mouse mammary gland involution
27. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: Association with an increased expression of TGF-β1 and its type-I and type-II receptors
28. Fenretinide. Induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cells
29. Evidence for role of transforming growth factor-β in RRR-α-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells
30. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
31. 2 in breast carcinoma cells
32. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity
33. Differences in susceptibility to tumor necrosis factor α-induced apoptosis among MCF-7 breast cancer cell variants
34. Predominant cytosolic localization of type II transforming growth factor β receptors in human breast carcinoma cells
35. Endogenous expression of transforming growth factor β1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model
36. TNF-α and TGF-β act synergistically to kill Schwann cells
37. Enhancement of apoptotic susceptibility in human endometrial epithelial cell line HHUA by transforming growth factor-β1
38. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells
39. Suppression of TNF-stimulated proliferation of diploid fibroblasts and TNF-induced cytotoxicity against transformed fibroblasts by TGF-β
40. 1 phase of the cell cycle
41. Immediate early upregulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways
42. Transforming growth factor β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2
43. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1
44. The AML1/ETO fusion protein activates transcription of BCL-2
45. Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibition by specific extracellular matrix proteins in mammary epithelial cells
46. Loss of receptors for transforming growth factor β in human T-cell malignancies
47. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
48. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells
49. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development
50. DPC4 gene in various tumor types
51. Inactivation of Smad4 in gastric carcinomas
52. Smad3 mutant mice develop metastatic colorectal cancer
53. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
54. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
55. Bcl-2 family proteins
56. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
57. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
58. Arsenic induced oxidant stress and NF-κB activation in cultured aortic endothelial cells
59. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers